HMGCS2 p.Ser371Cys
c.1112C>G · rs762536796 · VCV2138012
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1464 | likely benign |
|---|---|---|
| REVEL | 0.664 | pathogenic-leaning |
| SaProt | LLR -9.87 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 0.81, phastCons 1 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 18 kb · p 0.71 · regional, not allelic |
| Overall | ||
| CADD | 24.7 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.0333% | 3,000 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,606 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HMGCS2
- Protein
- p.Ser371Cys
- Coding
- c.1112C>G
- MANE Select
- NM_005518
- dbSNP
- rs762536796
- Type
- single nucleotide variant
- Location
- chr1:119755502 (GRCh38)
- Gene constraint
- LOEUF 1.111 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 92.00 · 1 PDB
- Residue 371
- an α-helix
Similar variants
- HMGCS2 c.1016+1G>A Pathogenic ★★ same condition
- HMGCS2 c.1187+1G>C Likely pathogenic ★★ same condition
- HMGCS2 c.685+2T>A Likely pathogenic ★★ same condition
- HMGCS2 p.Arg288Ter Pathogenic ★★ same condition
- HMGCS2 p.Arg424Ter Pathogenic/Likely pathogenic ★★ same condition
- HMGCS2 p.Arg500His Pathogenic/Likely pathogenic ★★ ⚠ same condition
- HMGCS2 p.Arg501Gln Likely pathogenic ★★ same condition
- HMGCS2 p.Arg501Pro Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hmgcs2-p-ser371cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown